Malignant neoplasm of stomach stage III

Known as: Stage III Gastric Cancer, Stage III Gastric Cancer AJCC v7, gastric cancer, stage III 
Stage III includes: IIIA (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0); IIIB (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0); IIIC (T4b, N2, M0… (More)
National Institutes of Health

Related topics

Related topics

10 relations
Epithelial CellsEpitheliumGastric mucosaGastrointestinal system
(More)

Narrower (1)

Stage III Carcinoma of Stomach

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Circular RNAs signature predicts the early recurrence of stage III gastric cancer after radical surgery
Tumor recurrence is usually detected within one year after radical resection of stage III gastric cancer. This study aimed to… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2017
2017
A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A)
Neoadjuvant chemotherapy (NAC) followed by radical surgery is a promising strategy to improve survival of patients with stage III… (More)
  • figure 1
  • table 1
  • table 3
  • table 4
  • table 2
Is this relevant?
2015
2015
Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
The Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer (ACTS-GC) demonstrated a survival benefit by adjuvant S-1 monotherapy… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Prognostic Value of the Lymph Node Ratio in Stage III Gastric Cancer Patients Undergoing Radical Resection
OBJECTIVE The aim of this study was to investigate the prognostic value of metastatic lymph node ratio (LNR) in patients having… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
 
Is this relevant?
2013
2013
Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
We have previously reported the superior feasibility and safety of adjuvant S-1 plus docetaxel in patients with stage III gastric… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2012
2012
Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
107 Background: The efficacy of S-1 for stage II-III gastric cancer has been shown. However, the survival of stage III remains… (More)
Is this relevant?
2004
2004
Randomized phase III trial of cisplatin, epirubicin, leucovorin, 5-fluorouracil (PELF) combination versus 5-fluorouracil alone as adjuvant chemotherapy in curative resected stage III gastric cancer.
PURPOSE The combination of cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) administration, as adjuvant chemotherapy… (More)
Is this relevant?
2002
2002
Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer.
In this paper, we present evidence that the red ginseng powder from Panax ginseng C.A. Meyer inhibits the recurrence of AJCC… (More)
Is this relevant?
1999
1999
Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer.
PURPOSE The efficacy of adjuvant chemotherapy in gastric cancer is controversial. We conducted a phase III, randomized… (More)
Is this relevant?